NUTEX Investments (BUD:NUTEX) Change In Receivables : Ft0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is NUTEX Investments Change In Receivables?

NUTEX Investments's change in receivables for the quarter that ended in Dec. 2023 was Ft0.00 Mil. It means NUTEX Investments's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

NUTEX Investments's change in receivables for the fiscal year that ended in Dec. 2023 was Ft0.00 Mil. It means NUTEX Investments's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

NUTEX Investments's Accounts Receivable for the quarter that ended in Dec. 2023 was Ft0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. NUTEX Investments's Days Sales Outstanding for the six months ended in Dec. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. NUTEX Investments's liquidation value for the six months ended in Dec. 2023 was Ft4,127.17 Mil.

NUTEX Investments Change In Receivables Historical Data

The historical data trend for NUTEX Investments's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NUTEX Investments Change In Receivables Chart

NUTEX Investments Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

2.51

NUTEX Investments Semi-Annual Data
	Dec13	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

NUTEX Investments Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was Ft0.00 Mil.

NUTEX Investments (BUD:NUTEX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

NUTEX Investments's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0.225	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, NUTEX Investments's accounts receivable are only considered to be worth 75% of book value:

NUTEX Investments's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4135.926	-	8.759	+	0.75 * 0	+	0.5 * 0
=	4,127.17

NUTEX Investments Change In Receivables Related Terms

Thank you for viewing the detailed overview of NUTEX Investments's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

NUTEX Investments (BUD:NUTEX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NUTEX Investments PLC (BUD:NUTEX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Telepes u. 53., Budapest, HUN, 1147

Website

http://www.nutex.hu

NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.

NUTEX Investments (BUD:NUTEX) Headlines

No Headlines